VAERS reports by lot

GSK Varicella/Shingles lot 3B2YJ: VAERS reports

54 VAERS reports list lot 3B2YJ as a GSK Varicella/Shingles vaccine, received between 2023-09-22 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
54
Reports
2%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2328%
General / Systemic (non-local)1721%
Musculoskeletal1316%
Neurological911%
Gastrointestinal810%
Allergic / Anaphylactic45%
Dermatological (non-injection-site)45%
Cardiac / Cardiovascular34%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia20
Ohio4
Pennsylvania4
California2
New York2
Alabama2
West Virginia1
Wisconsin1
Kentucky1
Massachusetts1
North Carolina1
Connecticut1

Reports by month received

2023-092
2023-107
2023-113
2023-1213
2024-0111
2024-025
2024-032
2024-054
2024-067

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.